Yukino Katakura

Kawasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

C-peptide Index under Non-fasting Conditions Can Predict the Likelihood of Future Insulin Therapy in Outpatients with Type 2 Diabetes Mellitus Not Receiving Insulin at Baseline.

C-peptide Index under Non-fasting Conditions Can Predict the Likelihood of Future Insulin Therapy in Outpatients with Type 2 Diabetes Mellitus Not Receiving Insulin at Baseline.

Journal: Internal medicine (Tokyo, Japan)

Published: November 19, 2025

Diabetic Ketoacidosis Associated with Non-occlusive Mesenteric Ischemia in a Subject with Type 2 Diabetes Mellitus.

Diabetic Ketoacidosis Associated with Non-occlusive Mesenteric Ischemia in a Subject with Type 2 Diabetes Mellitus.

Journal: Internal medicine (Tokyo, Japan)

Published: August 06, 2025

A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies, a multicenter retrospective cohort study.

A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies, a multicenter retrospective cohort study.

Journal: Journal of diabetes investigation

Published: February 12, 2025

Handgrip strength in patients with type 2 diabetes correlates with diabetic polyneuropathy. A single-center, retrospective observational study in Japanese patients.

Handgrip strength in patients with type 2 diabetes correlates with diabetic polyneuropathy. A single-center, retrospective observational study in Japanese patients.

Journal: Endocrine journal

Published: January 08, 2025

Comparison of Magnetic Resonance Imaging Features Between Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitor-Induced Hypopituitarism and Idiopathic Hypopituitarism in Japanese Subjects.

Comparison of Magnetic Resonance Imaging Features Between Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitor-Induced Hypopituitarism and Idiopathic Hypopituitarism in Japanese Subjects.

Journal: Cureus

Published: October 17, 2024

Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism.

Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism.

Journal: Scientific reports

Published: October 03, 2024

Morphological Differences in the Abdominal Aorta Between Subjects With and Without Type 2 Diabetes.

Morphological Differences in the Abdominal Aorta Between Subjects With and Without Type 2 Diabetes.

Journal: Cureus

Published: September 03, 2024

Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia.

Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia.

Journal: Internal medicine (Tokyo, Japan)

Published: August 28, 2024

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db mice.

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db mice.

Journal: Diabetes, obesity & metabolism

Published: June 21, 2024

Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching.

Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching.

Journal: Diabetes, obesity & metabolism

Published: May 25, 2024

Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients.

Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients.

Journal: Scientific reports

Published: May 14, 2024

Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).

Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).

Journal: Frontiers in endocrinology

Published: April 05, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026